Palatin Technologies (PTN) News Today $0.21 +0.01 (+7.83%) Closing price 04:10 PM EasternExtended Trading$0.19 -0.01 (-5.50%) As of 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Palatin Appeals NYSE American Notice of DelistingApril 14 at 7:00 AM | prnewswire.comPalatin receives NYSE American notice of delisting, plans to appealApril 12 at 12:13 AM | markets.businessinsider.comPalatin Technologies Reports Positive Data From Phase 2b BREAKOUT StudyApril 11, 2025 | nasdaq.comNYSE American to Commence Delisting Proceedings Against Palatin Technologies, Inc. (PTN)April 10, 2025 | tmcnet.comPalatin Technologies, Inc. Announces Receipt of NYSE American Notice of Delisting and Intention to AppealApril 10, 2025 | finance.yahoo.comPalatin to Present Positive Phase 2b Data for Melanocortin Agonist in Diabetic Kidney Disease at the National Kidney Foundation Spring MeetingApril 10, 2025 | prnewswire.comPalatin to Present Positive Phase 2b Data for Melanocortin Agonist in Diabetic Kidney Disease at the National Kidney Foundation Spring MeetingApril 10, 2025 | prnewswire.comPalatin: Bremelanotide-Tirzepatide Combination Achieves Primary Endpoint In Phase 2 Obesity StudyApril 2, 2025 | nasdaq.comPalatin says BMT-801 Phase 2 obesity study met primary endpointApril 1, 2025 | markets.businessinsider.comPalatin files to sell 17.32M shares of common stock, warrantsApril 1, 2025 | markets.businessinsider.comPalatin Announces MC4R Agonist Bremelanotide Co-Administered with GLP-1/GIP Tirzepatide Meets Primary Endpoint in Phase 2 Obesity StudyMarch 31, 2025 | prnewswire.comPalatin Announces Positive Topline Results from Phase 2 Ulcerative Colitis (UC) Study of Oral Melanocortin-1 Receptor Agonist PL8177March 28, 2025 | prnewswire.comPalatin Technologies, Inc.: Palatin's Oral MC4R Agonist PL7737 Receives FDA Orphan Drug Designation for Obesity Due to Leptin Receptor DeficiencyMarch 25, 2025 | finanznachrichten.dePalatin's Oral MC4R Agonist PL7737 Receives FDA Orphan Drug Designation for Obesity Due to Leptin Receptor DeficiencyMarch 25, 2025 | prnewswire.comHere's Why Palatin Technologies (PTN) Is a Great 'Buy the Bottom' Stock NowMarch 13, 2025 | msn.comPalatin Technologies, Inc. (PTN) Q2 2025 Earnings Call TranscriptFebruary 15, 2025 | seekingalpha.comPalatin Technologies, Inc. (AMEX:PTN) Q2 2025 Earnings Call TranscriptFebruary 14, 2025 | insidermonkey.comQ2 2025 Palatin Technologies Inc Earnings CallFebruary 14, 2025 | uk.finance.yahoo.comPalatin Technologies, Inc.: Palatin Reports Second Quarter Fiscal Year 2025 Financial Results and Provides Business UpdateFebruary 13, 2025 | finanznachrichten.dePalatin Reports Second Quarter Fiscal Year 2025 Financial Results and Provides Business UpdateFebruary 13, 2025 | prnewswire.comPalatin to Report Second Quarter Fiscal Year 2025 Results; Teleconference and Webcast to be held on February 13, 2025February 10, 2025 | prnewswire.comPalatin Gains on New OfferingFebruary 8, 2025 | baystreet.caPalatin Technologies Announces $4.7 Mln Direct OfferingFebruary 8, 2025 | markets.businessinsider.comPalatin secures $4.7 million in stock and warrant saleFebruary 8, 2025 | msn.comPalatin Announces $4.7 Million Registered Direct Offering and Concurrent Private PlacementFebruary 7, 2025 | prnewswire.comPalatin Technologies, Inc.: Palatin Completes Phase 2 Obesity Study With MC4R Bremelanotide Plus GLP-1/GIP TirzepatideFebruary 6, 2025 | finanznachrichten.dePalatin finishes phase 2 trial in obesity treatment studyFebruary 6, 2025 | msn.comPalatin Completes Phase 2 Obesity Study With MC4R Bremelanotide Plus GLP-1/GIP TirzepatideFebruary 6, 2025 | prnewswire.comPalatin gears up for obesity treatment trials in 2025January 28, 2025 | msn.comPalatin Provides Update on Anticipated 2025 Corporate MilestonesJanuary 28, 2025 | prnewswire.comPalatin Technologies, Inc.: Palatin Announces Positive Phase IIb BREAKOUT Study Results in Patients with Type 2 Diabetic NephropathyDecember 19, 2024 | finanznachrichten.dePalatin Announces Positive Results In Phase IIb Study Of Bremelanotide In Diabetic NephropathyDecember 19, 2024 | markets.businessinsider.comPalatin Announces Positive Phase IIb BREAKOUT Study Results in Patients with Type 2 Diabetic NephropathyDecember 19, 2024 | prnewswire.comPalatin Announces Exercise of Warrants for Approximately $3.4 Million Gross ProceedsDecember 16, 2024 | prnewswire.comPalatin completes patient enrollment in Phase 2 study of PL8177November 25, 2024 | markets.businessinsider.comBuy Rating for Palatin Technologies: Promising Pipeline and Strategic Initiatives in Obesity TreatmentNovember 25, 2024 | markets.businessinsider.comPalatin Completes Patient Enrollment In Phase 2 Study Of PL8177 In Ulcerative Colitis, Shares Up 16%November 25, 2024 | markets.businessinsider.comPalatin Announces Completion of Patient Enrollment in Phase 2 Study of Orally Administered Melanocortin Agonist PL8177 in Ulcerative ColitisNovember 25, 2024 | prnewswire.comPalatin Technologies Inc (PTN) Q1 2025 Earnings Call Highlights: Strategic Shifts Amid Revenue ...November 16, 2024 | finance.yahoo.comPalatin Technologies Shifts Focus to Obesity TreatmentsNovember 15, 2024 | markets.businessinsider.comPalatin Technologies: Strategic Focus on Obesity and Diversified Pipeline Justifies Buy RatingNovember 14, 2024 | markets.businessinsider.comPalatin Technologies, Inc. (PTN) Q1 2025 Earnings Conference Call TranscriptNovember 14, 2024 | seekingalpha.comPalatin Technologies Inc. Loss At -$7.82 Mln In Q1November 14, 2024 | markets.businessinsider.comPalatin Reports First Quarter Fiscal Year 2025 Operating/Financial ResultsNovember 14, 2024 | prnewswire.comPalatin Technologies Q1 2025 Earnings PreviewNovember 13, 2024 | msn.comPalatin to Report First Quarter Fiscal Year 2025 Results; Teleconference and Webcast to be held on November 14, 2024November 8, 2024 | prnewswire.comPalatin to report data from MC4R selective PL7737 obesity programNovember 5, 2024 | markets.businessinsider.comPalatin Technologies’ PL7737: A Promising Obesity Treatment Highlighted by New Preclinical DataNovember 5, 2024 | markets.businessinsider.comPalatin Presents Data on Novel Melanocortin 4 Receptor Selective Oral Small Molecule PL7737 Obesity Program at ObesityWeek® 2024November 4, 2024 | prnewswire.comPalatin Technologies: Promising Pipeline Advances and Positive Trial Developments Drive Buy RatingOctober 31, 2024 | markets.businessinsider.com Remove Ads Get Palatin Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for PTN and its competitors with MarketBeat's FREE daily newsletter. Email Address PTN Media Mentions By Week PTN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PTN News Sentiment▼0.010.78▲Average Medical News Sentiment PTN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PTN Articles This Week▼81▲PTN Articles Average Week Remove Ads Get Palatin Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for PTN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies GANX News ONCY News ARMP News PDSB News ACRV News SKYE News TNYA News IMMX News PVCT News OKUR News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSEAMERICAN:PTN) was last updated on 4/15/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Palatin Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Palatin Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PTN Stock Free PTN Stock Alerts